Opinions Jim Cramer - Mad Money
Emergent BioSolutions EBSWATCHDec 02, 2020
Jim Cramer - Mad MoneyUnknown
$81.95
Stock price when the opinion was issued
$8.49
As of Jun 01, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
SELL
A disaster. He feels bad for J&J that they ever signed a contract with them.
biotechnologypharmaceutical
BUY
Instead of buying a single vaccine-making pharma, consider this. They have an established vaccine business and are working on plasma-based treatments for Covid. They also have a big contract manufacturing business of vaccines with JNJ, AZN and Novavax. This has fallen $40 from its August peak. But last night they issued bullish future numbers for this year, and the stock jumped 4.7% today. More upside to come.
biotechnologypharmaceutical
They're involved with JNJ and will mass-produce their Covid vaccine. He expects JNJ will release the next effective vaccine. EBS stock has done nothing because there's no news yet.